<DOC>
	<DOC>NCT00728988</DOC>
	<brief_summary>This present study is specifically designed to examine the efficacy and safety of a high pre-treatment dose of atorvastatin in Asian patients with NSTE-ACS in China and the Republic of Korea, by using a treatment paradigm similar to that employed in the ARMYDA-ACS study.</brief_summary>
	<brief_title>Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>NonST elevated ACS; LDLC &gt; 80 mg/dl ST elevated acute myocardial infarction; previously or currently treated with atorvastatin or other statins</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Asia Lipitor Pre-treatment in Acute Coronary Syndrome</keyword>
</DOC>